Last week we reported on our brand new text mining technology developed by our team here at CiteAb. Today we’re looking at some very specific data we can access as a result of this new technology – insights into the antibodies used in prostate cancer research. CiteAb developer Matt Helsby said: “Using this new text […]
Today we return to our first ever data report, released three years ago, when we claimed that China was a market no supplier could ignore, and we look at new data to see whether our predictions came true. Back in 2014 we stated that ‘the data suggests that China is set to claim the lion’s […]
We recently announced that our team here at CiteAb has expanded our platform to cover multiple reagent types, and today we’re taking a first look at some of our new data. The inhibitors and activators used by life scientists to investigate cellular processes are collectively termed as ‘chemical probes’. They provide vital tools for […]
New to our series of blogs on antibody research applications, today we are exploring the top targets for ICC, or immunocytochemistry. ICC is the staining and microscopic examination of cells, which are often grown in culture. This is not to be confused with immunohistochemistry (IHC), which involves the staining of tissues with their normal organisation […]
As the vast majority of commercial antibodies are raised against human proteins, we became interested in taking a look at which commercial antibodies are being used by the zebrafish research community. Is the zebrafish research community using a subset of specialist antibodies raised for zebrafish research, or is it relying on anti-human antibodies cross reacting? […]
For the first time in 42 years, use of monoclonal antibodies has overtaken polyclonals in the research antibody market. Production of monoclonal antibodies was first described by Georges Köhler and César Milstein in 1975, and the pair were awarded the Nobel Prize in 1984. Monoclonal antibodies then became the dominant antibodies used in therapeutic and […]
Our latest data set outlines the protein targets most used for Chromatin Immunoprecipitation (ChIP) – it was created by our team looking specifically at antibody citations over the past ten years that carried out ChIP and working out what the most commonly used protein targets for the antibodies were. Dr Andrew Chalmers, founder of CiteAb, […]
In the data we’re releasing today we explore those antibody suppliers that are doing the most to support the study of post-translational modifications (PTMs). Post-translational modifications involve the covalent addition of groups such as phosphate or methyl moieties. The addition of these groups are commonly linked to regulation of protein function and so play a […]
Here at CiteAb we’re delighted to be launching our first custom data for sales teams in life science reagent suppliers. This new data helps sales teams improve their results, allowing them to both identify and contact researchers who are actually interested in purchasing antibodies, and to have more productive sales meetings backed by knowledge of […]
We’re just a few weeks out from the Society for Neuroscience’s annual event, so with this field at the front of our minds we’ve delved into CiteAb’s data to offer you a neuroscience special this week. Today we’re looking at data for the main antibody protein targets for neuroscience research – before reading ahead why […]
CiteAb is the largest citation-ranked antibody search engine and database. It provides an impartial way to find and compare antibodies that work.
We use our database of antibody publications to produce unique antibody market data, income from this data allows us to remain free to list and impartial.
Publication metadata is provided by PubMed®, a database of the US National Library of Medicine.
PubMed® is a registered trademark of US National Library of Medicine.
Company registered in England #08530854. VAT #179706954.
In partnership with
© CiteAb 2012-2015. All Rights Reserved.